Skip to main content
Update Location

My Location

Update your location to show providers, locations, and services closest to you.

Enter a zip code
Or
Select a campus/region

Gary P Wang, MD, PhD, FIDSA

Infectious Disease Specialist

Photo of Gary P Wang

About me

Gary P. Wang, MD, PhD, FIDSA, is Professor of Medicine and Chief of the Division of Infectious Diseases and Global Medicine in the Department of Medicine at the University of Florida. Dr. Wang graduated from Temple University School of Medicine in 2001 with MD and PhD degrees in biochemistry and mechanistic enzymology. He completed Internal Medicine Residency at Yale-New Haven Hospital, followed by Infectious Diseases Fellowship at Hospital of the University of Pennsylvania. Upon the completion of his clinical training, Dr. Wang pursued a postdoctoral research fellowship in Microbiology, Virology and Genomics with Dr. Rick Bushman at the University of Pennsylvania. He joined University of Florida in 2009 as an Assistant Professor, became Section Chief of Infectious Diseases at North Florida/South Georgia VA in 2014, and was appointed Division Chief of Infectious Diseases and Global Medicine in 2018. Dr. Wang was promoted to Associate Professor with tenure in 2016, and Professor of Medicine in 2022.

Active clinical trials

diSArm

Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available…

Investigator
Gary P Wang
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
PRIOH-1

Randomized, open-label, multi-center, comparative trial to assess the efficacy and safety in immunocompromised subjects with acyclovir resistant or acyclovir susceptible mucocutaneous HSV infection, treated with pritelivir 100 mg once daily…

Investigator
Gary P Wang
Status
Accepting Candidates
Ages
16 Years - N/A
Sexes
All
Mino-Lok

This is a Phase 3, multi-center, randomized, open-label, assess-blind study to determine the efficacy and safety of MLT, a novel antibiotic lock therapy that combines minocycline with edetate disodium in 25% ethanol solution as an adjuctive therapy…

Investigator
Gary P Wang
Status
Accepting Candidates
Ages
12 Years - N/A
Sexes
All

My research

Top areas of exploration

  • Sequence Analysis, DNA , 9 publications
  • Phylogeny , 6 publications
  • HIV Infections , 5 publications
  • Dysbiosis , 5 publications

Research activity

68 publications

3,666 citations

Why is this important?
View more of Gary Wang's research activity

Search our accepted insurances list

Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.

See all

My areas of focus